Prothrombin Suresnes: A case of homozygous F299V mutation responsible for hypodysprothrombinemia

Haematologica

Volumn 91, Issue 3, 2006, Pages 431-432

  François, Dominique ^a   Chevreaud, Caroline ^b   Vignon, Dominique ^a   De Mazancourt, Philippe ^b,c  

^a FOCH HOSPITAL   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c INRA Institut National de la Recherche Agronomique   (France)

Author keywords

Hypodysprothrombinemia; Mutation; Prothrombin deficiency

Indexed keywords

BLOOD CLOTTING FACTOR 10A; PROTHROMBIN;

ARTICLE; BLOOD DISEASE; CATALYST; GENE MUTATION; GEOMETRY; HUMAN; HYPODYSPROTHROMBINEMIA;

ADULT; FEMALE; HOMOZYGOTE; HUMANS; HYPOPROTHROMBINEMIAS; MUTATION; PHENYLALANINE; PROTHROMBIN; PROTHROMBIN TIME; VALINE;

EID: 33645455819     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Degen SJF, Davie EW. Nucleotide sequence of the gene for human prothrombin. Biochemistry 1987;26:6165-77.
2. Acharya SS, Coughlin A, Dimichele DM. North American rare bleeding disorder study group. Rare bleeding disorder registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004;2:248-56.
3. De Cristofaro R, Akhavan S, Altomare C, Carotti A, Peyvandi F, Mannucci PM. A natural prothrombin mutant reveals an unexpected influence of A-chain structure on the activity of human alpha-thrombin. J Biol Chem 2004;279:13035-43.
4. Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L. Cross-laboratory audit of normal reference ranges and assessment of ABO blood group, gender and age on detected levels of plasma coagulation factors. Blood Coagul Fibrinol 2005;16:597-605.
5. Norris LA, Bonnar J. Haemostatic changes and the oral contraceptive pill. Baillieres Clin Obstet Gynaecol 1997;11:545-64.
6. Raoul M, Mathonnet F, Peltier JY, Collet C, Boucly C, Van Amerongen G, et al. An improved method for the detection of the G20210A transition in the prothrombin gene. Thromb Res 1997;88:441-3.
7. Bode W, Turk D, Karshikov A. The refined 1.9 Å crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human α-thrombin: structure analysis, overall structure, electrostatic properties, detailed active site geometry, and structure-function relationships. Protein Sci 1992;1:426-71.
8. Akhavan S, Mannucci PM, Lak M, Mancuso G, Mazzucconi MG, Rocino A, et al. Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency. Thromb Haemost 2000;84:989-97.
9. Chen L, Rezaie AR. Proexosite-1-dependent recognition and activation of prothrombin by Taipan venom. J Biol Chem 2004;279:17869-74.